Microbio - Niche Infections and the Globo Ones Flashcards
Rapid neurological degeneration with normal Ix think
Prion disease
Type of encephalopathy in prion disease
Spongifom
Prion protein - normal and changes in disease
Prion protein gene on chromosome 20 - mainly expressed in CNS
When it is in a-helical structure it is protease sensitive, however when it is in the b-pleated sheet configuration it is not.
Prion disease promotes irreversible conversion from a-helical to B-pleated sheet.
Trigger remains unclear in sporadic cases.
Prion Disease Classification
Sporadic:
Creutzfeldt-Jakob Disease (80%)
Acquired (<5%):
- Kuru
- variant CJD
- iatrogenic CJD: GH, Blood, Surgery
Genetic (15%):
PRNP mutations
eg. Gerstmann-Straussler-Sheinker syndrome, Familial Fatal Insomnia
Sporadic CJD - presentation, epi, causes
Rapid dementia with: myoclonus, cortical blindness, akinetic mutism, LMN signs
Mean age onset 65 yrs (range 45-75 yrs)
Incidence 1/million/year
Death within 6/12
Cause uncertain
- ? somatic PRNP mutation
- ? spontaneous conversion of PrPc to PrPsc
- ?? Environmental exposure to prions
Sporadic CJD - Diagnosis
- EEG - periodic, triphasic complexes (non-specific), 2/3 abnormal
- MRI- basal ganglia – increased signal
cortical/striatal signal change on diffusion weighted imaging MRI - CSF increased 14-3-3 protein, S100 (markers of neuronal damage)
- Neurogenetics to r/o genetic cause
- Tonsillar biopsy NOT useful
- Brain biopsy
- Autopsy – by experienced pathologist - spongiform vacuolation and PrP amyloid plaques
Sporadic CJD - Differentials
Alzheimer’s disease Vascular dementia Mixed dementia (AD + vascular) CNS neoplasm eg. glioma, metastases Cerebral vasculitis Paraneoplastic syndrome Familial CJD vCJD
Variant CJD - Background
- Atypical CJD in teenagers and young people
- First reported in 1990s in 1990s
- Thought to link to mad cow disease (BSE)
- Younger age of onset (median age 26 yrs)
- Median survival time 14 months
- Psychiatric onset: dysphoria, anxiety, paranoia, hallucinations
- Then neurological: peripheral sensory symptoms, ataxia, myoclonus, chorea, dementia
vCJD- Diagnosis
- MRI brain - positive pulvinar sign (bilateral FLAIR hyperintensities involving the pulvinar thalamic nuclei)
- EEG – non-specific slow waves
- CSF – 14.3.3, S100 not useful
- Neurogenetics (almost 100% are MM at codon 129 so far)
- Tonsil biopsy 100% sensitive and specific –> eliminates need for further investigation to exclude other treatable causes, important for therapeutic trials and early treatment. May be positive in incubation period prior to clinical onset. See FLORID PLAQUES.
- (Brain biopsy)
- Autopsy
- PrPSc type 4t detectable in CNS + most lympo-reticular tissues
Iatrogenic CJD - Causes
Human cadaveric growth hormone
Corneal transplants
Neurosurgical procedures eg. dural grafts, pre-1991
Blood transfusions, other blood products
Other surgical procedures? - appendicectomy and tonsillectomy in vCJD
Iatrogenic CJD - Clinical Features
Progressive ataxia initially
Dementia and myoclonus later stages
Speed of progression depends on route of inoculation (CNS inoculation fastest)
Prion Genetics
3 Aspects:
Codon 129 polymorphism
- Methionine – Methionine (MM) - found in nearly 100% of vCJD
- Methionine – Valine (MV)
- Valine – Valine (VV)
Specific PRNP mutations (~30 so far, all AD)
Consider other neuro-genetic conditions eg. Huntington’s, spinocerebellar ataxia
Familial Prion Disease - GSS, FFI, CJD
Fix is crucial: dementian, “MS”, ataxia, psych
- EEG - non-specific
- MRI - basal ganglia: sometimes high signal
- Neurogenetics crucial
- If -ve: SCA, Huntington’s
- Autopsy
Familial Prion Disease - GSS(Gerstmann-Straussler-Scheinker syndrome)
Slowly progressive ataxia
Diminished reflexes
Dementia
Onset age 30-70 years
Survival 2-10 years
PRNP P102L, but several other mutations
Familial Prion Disease - Familial Fatal Insomnia (FFI)
Untreatable insomnia --> psych issues Dysautonomia Ataxia (thalamic degeneration) PRNP D178N +/ pyramidal/extrapyramidal signs, late cognitive decline
Kuru
Longest incubation - up to 45 years
From endocannabolism
Progressive cerebellar syndrome –> death within 2 years
Dementia late or absent
CJD Treatment
Symptomatic: clonazepam – mycolonus (can also give valproate, levetiracetam, piracetam)
Delaying prion conversion:
- quinacrine
- pentosan (intra-ventricular administration)
- tetracycline
Anti-prion antibody (prevents peripheral prion replication and blocks progression to disease in infected mice but does not get into CNS)
Depletion of neuronal cellular prion protein (prevents onset of disease in mice and blocks neuronal cell loss + reverses early spongiosis)
Fungi - Types of Yeast
Candida
Cryptococcus
Histoplasma (Dimorphic)
Fungi - Types of Moulds
Aspergillus
Dermatophytes
Agents of mucormycosis
Candida - Gram Stain
+ve budding yeast
Candidiasis
Primary or secondary mycotic infection caused by members of the genus Candida.
Clinical manifestations:
- Acute, subacute or chronic, episodic.
- Involvement may be localized to the mouth, throat, skin, scalp, vagina, fingers, nails, bronchi, lungs, or the gastrointestinal tract, or become systemic as in septicaemia, endocarditis and meningitis.
Distribution: World-wide.
Aetiological Agents: Candida albicans, C. glabrata, C. tropicalis, C. krusei. C. parapsilosis, C. guilliermondii and C. pseudotropicalis.
All are ubiquitous and occur naturally on humans.
Screening test for C. albicans - characteristic germ tubes on fluorescence?
Candida Endophtalmitis
- Often associated with candidemia, indwelling catheters or drug abuse, however it is rare in patients with severe neutropenia.
- Lesions are often localized near the macula and patients complain of cloudy vision.
- Exogenous Candida endophthalmitis is rare, but cases have been reported following ocular trauma or surgery.
- Similarly, conjunctival and corneal infections have also been recorded following trauma.
Chronic oral candidiasis
- Tongue and mouth corners (angular cheilitis)
- Suggests underlying immune deficiency.
- Characteristic white pseudomembrane composed of cells and pseudohyphae of C. albicans.
Stain for invasive candidiasis postmortem
Periodic Acid-Schiff (PAS) stained section.
Blastoconidia and branched pseudohyphae.
Candidiasis - Diagnosis
- Blood cultures for candidaemia, other samples for short term fungal culture.
- B D Glucan assay (serology)
- Imaging e.g. for hepatosplenic candidaisis
Candidiasis - Rx
- At least 2 weeks of antifungals from first negative blood cultures.
- ECHO and fundoscopy
- Echinicandin empirically and for non-albicans Candida
- Fluconazole for Candida albicans
- Ambisome (e.g. CNS), Fluconazole (e.g. urine) or Voriconazole (e.g. CNS) for organ-based disease.
Cryptococcosis
- Chronic, subacute to acute pulmonary, systemic or meningitic disease
- Initiated by the inhalation of the fungus.
- Primary pulmonary infections have no diagnostic symptoms and are usually subclinical.
- On dissemination, the fungus usually shows a predilection for the central nervous system, however skin, bones and other visceral organs may also become involved.
Distribution: World-wide.
Aetiological Agent: Cryptococcus neoformans.
Susceptibility greatly increased in pts with impaired T-cell immunity e.g. AIDS (2nd most common cause of death in AIDS)
Life cycle: eucalyptus tree –> bird excreta –> spores –> inhaled –> alveoli –> CNS
Crytococcus neoformans var. gattii
Causes a meningitis in apparently immunocompetent individuals in tropical latitudes, esp. SE Asia and Australia
High incidence of space-occupying lesions in brain and lung
Increased resistance to amphotericin B clinically
Cryptococcal Meningitis CSF stain
India ink - budding yeast cell surrounded by characteristic wide gelatinous capsule.
Cryptococcomas on MRI appear as
discrete white masses
Cryptococcus gattii on agar
typical brown colour effect due to phenol oxidase activity.
Cryptococcosis - Diagnosis
Diagnosis almost entirely around detection of Cryptococcal antigen in blood or CSF
Typical clinical features
Immunosuppressed host
Often culturable from blood, body fluids
Cryptococcosis - Management
3/52 Amphotericin B +/- flucytosine
Repeat LP for pressure management
Secondary suppression with fluconazole
Some evidence that high dose fluconazole effective
Aspergillosis - Genera
- Spectrum of diseases of humans and animals caused by members of the genus Aspergillus including:
(1) mycotoxicosis due to ingestion of contaminated foods
(2) allergy and sequelae to the presence of conidia or transient growth of the organism in body orifices
(3) colonization without extension in preformed cavities and debilitated tissues
(4) invasive, inflammatory, granulomatous, necrotizing disease of lungs, and other organs
(5) systemic and fatal disseminated disease (rare). - The type of disease and severity depends upon the physiologic state of the host and the species of Aspergillus involved.
Distribution: World-wide.
Aetiological Agents: Aspergillus fumigatus, A. flavus, A. niger, A. nidulans and A. terreus.
Aspergillus stain
Methenamine silver (GMS) –> fungal hyphae - balls or dichotomously branched